April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Covid vaccine 5-11 years, Ema: “In autumn the data” Sep 9, 2021
- Mávila Huertas receives first dose of the coronavirus vaccine Jul 6, 2021
- New York launches cyber defense center in the heart of Manhattan Jul 9, 2021
- Named five rules to guarantee weight loss Jul 13, 2020
- In South Korea 179 patients again ill COVID-19 Apr 20, 2020
- Named diet, recommended by science Jul 2, 2020
- Jalisco Coronavirus: The SSj adds more than 345 thousand positive cases Sep 6, 2021
Maxie Eckert
Today at 11:34 AM
.
